Peer Review reports
From: An IGF-1R-mTORC1-SRPK2 signaling Axis contributes to FASN regulation in breast cancer
Original Submission | ||
---|---|---|
13 Apr 2022 | Submitted | Original manuscript |
7 May 2022 | Reviewed | Reviewer Report |
31 May 2022 | Reviewed | Reviewer Report - Andrea Morrione |
9 Jun 2022 | Author responded | Author comments - Linda deGraffenried |
Resubmission - Version 2 | ||
9 Jun 2022 | Submitted | Manuscript version 2 |
29 Jun 2022 | Author responded | Author comments - Linda deGraffenried |
Resubmission - Version 3 | ||
29 Jun 2022 | Submitted | Manuscript version 3 |
7 Jul 2022 | Author responded | Author comments - Linda deGraffenried |
Resubmission - Version 4 | ||
7 Jul 2022 | Submitted | Manuscript version 4 |
8 Jul 2022 | Author responded | Author comments - Linda deGraffenried |
Resubmission - Version 5 | ||
8 Jul 2022 | Submitted | Manuscript version 5 |
5 Aug 2022 | Reviewed | Reviewer Report |
6 Aug 2022 | Reviewed | Reviewer Report - Andrea Morrione |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
10 Aug 2022 | Editorially accepted | |
12 Sep 2022 | Article published | 10.1186/s12885-022-10062-z |
You can find further information about peer review here.